Mounjaro monthly cost in the UK: what the price really covers

Why the monthly cost of Mounjaro in the UK shifted — and what you should expect to pay

Before September 2025, a single Mounjaro KwikPen at the highest dose carried a UK list price of roughly £122. Eli Lilly then repriced the range; that same pen now has a list price of around £330. If you want a clear breakdown of how much Mounjaro will cost from September, the repricing affects private providers differently, which is why the monthly cost of Mounjaro in the UK now spans a wider band than it did two years ago, typically reported at £149 to £375 across doses and clinics, with lower doses sitting at the cheaper end. These figures are widely reported and should be treated as a market guide rather than a fixed tariff.

A question our prescribers hear most weeks is whether all providers are quoting for the same thing. They often aren't. Some prices are per-pen only; others bundle in clinical oversight, aftercare and prescriptions. Comparing the headline number alone, without checking what it covers, is roughly like comparing two boiler quotes where one includes parts and one doesn't. More on that below.

NICE's appraisal of tirzepatide (published as TA1026) gives a useful picture of where the clinical evidence sits and why NHS eligibility thresholds are set where they are. Private provision follows the same licensed criteria, just without the waiting list.

What headline prices often leave out, and why that changes the comparison

Price transparency across the market is uneven. A low monthly figure sometimes excludes the consultation (charged separately, often £30–£50), the prescription fee, delivery, and any cost for clinical support between doses. Add those back and the gap between the cheapest and mid-market providers narrows considerably, and our guide to the cheapest monthly Mounjaro options walks through exactly what to check before you assume a low headline figure is a genuine saving. A few things worth checking before you commit to any provider:

Does the price include an actual clinical assessment, or is it a form you fill in and an algorithm flags? Is there a prescriber you can contact if something doesn't feel right? Is delivery included, tracked, and reliably next-working-day? What happens if you need a dose review, is there an additional charge? These are practical questions, not rhetorical ones. At nume (at nume) sorry. At nume, the price you see on the treatment page covers all of it.

It's also worth reading the NHS page on tirzepatide, which sets out clearly that this is a prescription-only medicine supplied following clinical assessment, not something that can or should be sourced without one.

Where nume sits on price, and why we're honest about not being cheapest

Cheapest isn't a race we entered. Our pricing is set to cover what responsible private supply actually costs: a GPhC-registered pharmacy (premises number 9012878, verifiable on the GPhC register), a named prescriber reading your consultation the same day it arrives, genuine UK supply chain sourcing, and aftercare that continues through your treatment, not just until your first pen arrives. Every repeat order gets a fresh clinical review before it ships. There are no subscriptions.

The current price for your dose is shown clearly on our treatment page. We don't print per-pen prices in body copy because the right starting dose is a clinical call, not a shopping decision. If you want to understand the full tirzepatide monthly cost across a course of treatment, that page sets out the context in full, and you can explore our Mounjaro monthly payment options if that's helpful for planning.

Some readers arrive here having seen discount codes or vouchers advertised for Mounjaro online. We don't run them, not because we forgot to, but because a promotional code attached to a prescription medicine from an unverifiable seller is a serious warning sign. The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million at street value, some containing insulin rather than the stated active ingredient. If a seller is offering Mounjaro below plausible market prices with a promotional code and no evident clinical pathway, that is a red flag worth taking seriously. You can report suspect sellers directly at the MHRA's Yellow Card scheme.

The question price can't answer, and what can

For any prescription medicine, 'cheapest' tests the wrong thing. The question that actually matters is whether your supply is genuine, clinically appropriate for you, and supported if something changes. Mounjaro's results in clinical trials (up to around 20–21% average body-weight reduction at the highest dose over 72 weeks, as reported in the SURMOUNT-1 trial in the New England Journal of Medicine) depend on consistent, correctly titrated supply under clinical oversight. A saving of a few pounds per pen means very little if the product isn't genuine, the dose isn't right, or there's no one to call when you have a question at 7pm on a Saturday.

If you're weighing up whether the monthly cost makes sense for your situation, the most useful next step is a free consultation. A prescriber can assess your eligibility, explain what to expect at each stage of titration, and answer the specific questions that a price comparison can't. You can also read about typical monthly weight loss on Mounjaro to get a clearer sense of what you're working towards. For a broader look at private weight management options, our weight-loss overview covers the full picture.